|
February 5, 2001 |
Updated guidelines for the use of antiretroviral agents in
HIV-infected adults and adolescents. |
|
March 10, 2000 |
Updated guidelines for the use of Rifabutin or Rifampin for
the treatment and prevention of Tuberculosis among HIV-infected
patients taking protease inhibitors or nonnucleoside reverse
transcriptase inhibitors. |
|
February 25, 2000 |
U.S. Public Health Service Task Force recommendations for
the use of antiretroviral drugs in pregnant women infected
with HIV-1 for maternal health and for reducing perinatal
HIV-1 Transmission in the United States. |
|
January 28, 2000 - check |
Guidelines for the use of antiretroviral agents in HIV-infected
adults and adolescents. |
|
January 7, 2000 |
Guidelines for the use of antiretroviral agents in pediatric
HIV infection. |
|
August 20, 1999 |
1999 USPHS/IDSA guidelines for the prevention of opportunistic
infections in persons infected with Human Immunodeficiency
Virus. |
|
May 5, 1999 |
Guidelines for the use of antiretroviral agents in HIV-infected
adults and adolescents. |
|
March 1, 1999 |
Guidelines for the use of antiretroviral agents in pediatric
HIV infection. |
|
October 30, 1998 |
Prevention and treatment of Tuberculosis among patients infected
with Human Immunodeficiency Virus: Principles of Therapy and
Revised Recommendations. |
|
October 16, 1998 |
Recommendations for prevention and control of Hepatitis C
Virus (HCV) infection and HCV-related chronic disease. |
|
September 25, 1998 |
Management of possible sexual, injecting-drug-use, or other
nonoccupational exposure to HIV, including considerations
related to antiretroviral therapy. |
|
September 4, 1998 |
Hepatitis A Vaccination of men who have sex with men- Atlanta,
GA. |
|
August 28, 1998 |
Success in implementing PHS guidelines to reduce perinatal
transmission of HIV- 1993, 1995, and 1996. |
|
July 31, 1998 |
HIV prevention through early detection and treatment of other
sexually transmitted diseases. |
|
May 15, 1998 |
Public health service guidelines for the management of health-care
worker exposures to HIV and recommendations for postexposure
prophylaxis. |
|
April 24, 1998 |
Report of the NIH panel to define principles of therapy of
HIV infection and guidelines for the use of antoretroviral
agents in HIV-infected adults and adolescents. |
|
January 30, 1998 |
Public Health Service Task Force recommendations for the use
of antiretroviral drugs in pregnant women infected with HIV-1
for maternal health and for reducing perinatal HIV-1 transmission
in the United States. |
|
September 5, 1997 |
Anergy skin testing and preventative therapy for HIV-infected
persons: revised recommendations. |
|
June 27, 1997 |
1997 USPHS/IDSA guidelines for the prevention of opportunistic
infections in persons infected with Human Immunodeficiency
Virus. |
|
January 23, 1997 |
1998 guidelines for treatment of sexually transmitted diseases.
|
|
January 10, 1997 |
1997 revised guidelines for performing CD4+ T-Cell determinations
in persons infected with Human Immunodeficiency Virus. |
|
October 25, 1996 |
Impact of HIV protease inhibitors on the treatment of HIV-infected
tuberculosis patients with Rifampin. |
|
May 10, 1996 |
Community-level prevention of human immunodeficiency virus
infection among high-risk populations: the AIDS Community
Demonstration Projects. |
|
March 1, 1996 |
U.S. Public Health Service guidelines for testing and counseling
blood and plasma donors for Human Immunodeficiency Virus Type
1 Antigen. |
|
July 7, 1995 |
U.S. Public Health Service recommendations for Human Immunodeficiency
Virus counseling and voluntary testing for pregnant women.
|
|
April 28, 1998 -check |
1995 revised guidelines for prophylaxis against Pneumocystis
carinii Pneumonia for children infected with or perinatally
exposed to Human Immunodeficiency Virus. |
|
August 5, 1994 |
Recommendations of the U.S. Public Health Service Task Force
on the use of Zidovudine to reduce perinatal transmission
of Human Immunodeficiency Virus. |
